What is the most effective regenerative medicine for knees?
What works for a knee depends on what is wrong with it. For arthritis — the commonest problem — exercise, weight loss (semaglutide cut knee arthritis pain sharply in a trial) and a steroid injection for flares beat every regenerative option; PRP helps a little; stem-cell injections have not beaten placebo. For a specific cartilage defect in a younger knee, cartilage cell implantation (MACI) is approved and works. For a worn meniscus, exercise equals surgery. Get the diagnosis first.
The most effective regenerative medicine for a knee depends on what is wrong with it, and for the commonest problem — osteoarthritis — the most effective treatments are not regenerative. Ranked by diagnosis: for knee osteoarthritis, structured exercise (strongest evidence of any intervention), weight loss with semaglutide where obesity is present (a randomised trial showed large pain reduction), a corticosteroid injection for flares, and PRP as a modest adjunct; hyaluronic acid gives small brief benefit; bone-marrow and adipose 'stem cell' injections have not beaten placebo consistently and are not approved. For a focal cartilage defect in a younger knee, autologous chondrocyte implantation (MACI) is approved and outperforms microfracture — the one genuinely effective regenerative knee treatment, for that indication only. For a degenerative meniscal tear, exercise therapy matches arthroscopic surgery in randomised trials; for a ligament injury, rehabilitation with or without reconstruction depending on instability. Exosomes and clinic 'stem cell' products have no evidence for any knee diagnosis. Get the diagnosis first; the most effective treatment follows from it.
- 'Knee pain' is four diagnoses — osteoarthritis, cartilage defect, meniscal tear, ligament injury — and the most effective treatment differs for each.
- For osteoarthritis, exercise and weight loss outperform every injection, and semaglutide is the most effective drug treatment in a randomised trial.
- MACI is the effective regenerative knee treatment — for a focal cartilage defect, typically after injury, in a younger patient.
- Arthroscopy for a degenerative meniscal tear is no better than exercise in randomised trials.
- PRP is a modest adjunct; stem-cell injections are unproven; exosomes are untested.
Knee treatments ranked, by diagnosis
Ranked on: randomised evidence for pain, function and structural outcomes in the specific knee diagnosis the treatment is offered for, weighted by effect size, durability, safety and approval status. The diagnosis is named on every line.
| # | Option | Verdict | Grade |
|---|---|---|---|
| 1 | Structured exercise therapy — knee osteoarthritis | Strongest evidence of any intervention | GRADE AEstablished |
| 2 | Weight loss with semaglutide where obesity is present — knee osteoarthritis | The most effective drug treatment in a randomised trial | GRADE AEstablished |
| 3 | Autologous chondrocyte implantation (MACI) — focal cartilage defect | The effective regenerative knee treatment, for its indication | GRADE AEstablished |
| 4 | Exercise therapy — degenerative meniscal tear | Matches arthroscopy in randomised trials | GRADE AEstablished |
| 5 | Rehabilitation, with reconstruction if unstable — ligament injury | Rehab first; surgery for instability | GRADE AEstablished |
| 6 | Corticosteroid injection — osteoarthritis flare | Weeks of relief; cartilage cost with repetition | GRADE BPromising |
| 7 | PRP injection — knee osteoarthritis | Modest adjunct; inconsistent trials | GRADE CEarly |
| 8 | Hyaluronic-acid injection — knee osteoarthritis | Small, brief, safe | GRADE CEarly |
| 9 | Bone-marrow aspirate, adipose SVF or cultured MSC injection — knee osteoarthritis | Not consistently better than placebo; not approved | GRADE CEarly |
| 10 | Exosomes, 'IV stem cells', imported cell products — any knee diagnosis | No evidence; harm record | GRADE DInsufficient or unsafe |
- 01
Structured exercise therapy — knee osteoarthritis
GRADE AEstablishedStrongest evidence of any interventionSupervised strengthening of the quadriceps and hip, mobility and aerobic work reduce pain and improve function in knee osteoarthritis across dozens of randomised trials, with effects comparable to analgesics and durable beyond the programme. Every guideline's first line; most patients' last resort.
- 02
Weight loss with semaglutide where obesity is present — knee osteoarthritis
GRADE AEstablishedThe most effective drug treatment in a randomised trialIn a randomised, placebo-controlled trial in people with obesity and knee osteoarthritis, weekly semaglutide produced substantial weight loss and a large reduction in knee pain scores versus placebo over 68 weeks. Weight loss by any means helps; this trial showed how much. Indicated by the obesity, not the knee alone.
- 03
Autologous chondrocyte implantation (MACI) — focal cartilage defect
GRADE AEstablishedThe effective regenerative knee treatment, for its indicationFor a defined full-thickness cartilage defect, typically after injury in a patient under fifty, a patient's own cartilage cells are expanded and implanted; randomised trials show better function than microfracture at two to five years. Approved. Not a treatment for the diffuse cartilage loss of osteoarthritis.
- 04
Exercise therapy — degenerative meniscal tear
GRADE AEstablishedMatches arthroscopy in randomised trialsIn middle-aged patients with a degenerative meniscal tear, supervised exercise produced outcomes equivalent to arthroscopic partial meniscectomy in randomised trials, without the surgery. Arthroscopy for this diagnosis is now discouraged by guidelines.
- 05
Rehabilitation, with reconstruction if unstable — ligament injury
GRADE AEstablishedRehab first; surgery for instabilityFor anterior cruciate ligament injury, structured rehabilitation with delayed reconstruction only if instability persists produced outcomes comparable to early reconstruction in randomised trials. Regenerative injectables have no role.
- 06
Corticosteroid injection — osteoarthritis flare
GRADE BPromisingWeeks of relief; cartilage cost with repetitionReliable short-term relief; randomised evidence that repeated injections over years accelerate cartilage loss. Use to get back to exercise, a few times a year at most.
- 07
PRP injection — knee osteoarthritis
GRADE CEarlyModest adjunct; inconsistent trialsMeta-analyses show PRP outperforms hyaluronic acid on pain at six to twelve months and less consistently outperforms placebo; the largest placebo-controlled trial found no benefit on pain or cartilage at twelve months. Preparation varies widely. Low risk. A reasonable one-course trial once exercise and weight are in place.
- 08
Hyaluronic-acid injection — knee osteoarthritis
GRADE CEarlySmall, brief, safeMany trials, small benefit over placebo that several guidelines judge not clinically important, lasting weeks to months. Safe; low value.
- 09
Bone-marrow aspirate, adipose SVF or cultured MSC injection — knee osteoarthritis
GRADE CEarlyNot consistently better than placebo; not approvedRandomised trials are inconsistent and the better-controlled ones show no advantage over placebo or hyaluronic acid on pain or cartilage; no product is approved for osteoarthritis. Clinic preparations are unregulated. Outside a trial, no.
- 10
Exosomes, 'IV stem cells', imported cell products — any knee diagnosis
GRADE DInsufficient or unsafeNo evidence; harm recordNo randomised evidence for any knee diagnosis, unverified composition, regulatory warnings, and documented infections from unapproved products. Refuse.
Diagnosis first
What is wrong with the knee, and what works
| Diagnosis | Typical patient | Most effective treatment | Regenerative option with evidence | What does not work |
|---|---|---|---|---|
| Osteoarthritis | Over 45; gradual pain; stiffness | Exercise; weight loss (semaglutide if obese); steroid for flares | None approved; PRP modest | Stem-cell injections; exosomes; arthroscopy |
| Focal cartilage defect | Under 50; after injury; locking or catching | MACI or microfracture, by size | MACI — approved | Injections of any kind |
| Degenerative meniscal tear | Middle-aged; mechanical symptoms with wear | Exercise therapy | None | Arthroscopy (no better than exercise) |
| Ligament injury | Younger; sport; instability | Rehabilitation; reconstruction if unstable | None | Injectables |
| Patellofemoral pain | Younger; anterior pain with stairs | Hip and quadriceps strengthening | None | Injections; surgery |
Frequently asked questions
What is the most effective regenerative medicine for knees?
It depends on the diagnosis. For osteoarthritis, the commonest problem, the most effective treatments are not regenerative: structured exercise, weight loss with semaglutide where obesity is present, and a steroid injection for flares; PRP is a modest adjunct and stem-cell injections have not beaten placebo. For a focal cartilage defect in a younger knee, autologous chondrocyte implantation (MACI) is approved and outperforms microfracture — the one effective regenerative knee treatment, for that indication only.
Does semaglutide help knee osteoarthritis?
Yes, in a randomised, placebo-controlled trial in people with obesity and knee osteoarthritis: weekly semaglutide produced substantial weight loss and a large reduction in knee pain scores over 68 weeks. It is indicated by the obesity rather than the knee, and it is the most effective drug treatment for this knee that a trial has shown.
Are stem cell injections effective for knee arthritis?
Not consistently. Randomised trials of bone-marrow, adipose and cultured mesenchymal cell injections are mixed, and the better-controlled ones find no advantage over placebo or hyaluronic acid on pain or cartilage. No cell product is approved for osteoarthritis and clinic preparations are unregulated. I would not have one outside a clinical trial.
Is MACI effective, and who is it for?
Yes, for a defined full-thickness cartilage defect — typically after injury in a patient under fifty — where a patient's own expanded cartilage cells are implanted, with randomised evidence of better function than microfracture at two to five years. It is approved. It does not treat the diffuse cartilage loss of osteoarthritis, and it is not what clinics offering 'stem cell therapy' provide.
Should I have arthroscopy for a torn meniscus?
For a degenerative tear in a middle-aged knee, no: supervised exercise produced equivalent outcomes to arthroscopic partial meniscectomy in randomised trials, and guidelines now discourage the surgery for this diagnosis. A traumatic tear with locking in a younger knee is a different situation and a surgical opinion.
Is PRP worth it for a knee?
As a one-course adjunct once exercise and weight are addressed, with modest expectations. Meta-analyses show benefit over hyaluronic acid and inconsistent benefit over placebo; the largest placebo-controlled trial found no difference at twelve months. It is low-risk and unstandardised. Judge it honestly at six months and do not let it replace step one.
Keep reading
- Which regenerative medicine treatments work best for joint pain?
All joints, ranked on the same scale.
- Regenerative medicine: what is approved, what is in trials, and what is only being sold
The full evidence ledger, including MACI and the MSC trials.
- Mounjaro vs Ozempic
The GLP-1 agonists compared.
- Best longevity workout routine for healthy aging adults
The strengthening that is step one.
More in Regenerative medicine
- Which regenerative medicine treatments work best for joint pain?
Regenerative treatments for joint pain ranked against what actually works: exercise therapy and weight loss, GLP-1 agonists for knee OA, corticosteroid and hyaluronic-acid injections, PRP, bone-marrow and adipose stem-cell injections, autologous chondrocyte implantation, exosomes and clinic 'stem cells' — with a pharmacist's advice on what to try first.
- Which regenerative medicine options help avoid joint replacement?
Options for delaying or avoiding joint replacement ranked on evidence: exercise and weight loss, GLP-1 agonists, bracing and offloading, osteotomy, MACI for cartilage defects, steroid and PRP injections, stem-cell injections, exosomes — and when delaying a replacement does more harm than the operation.
- What regenerative medicine is best for chronic back pain?
Chronic back pain treatments ranked on randomised evidence: exercise and cognitive-behavioural approaches, multidisciplinary rehabilitation, staying active, epidural and facet injections, radiofrequency ablation, intradiscal PRP and cell injections, basivertebral nerve ablation, spinal fusion — and the regenerative injections that have not beaten placebo.
- Which regenerative medicine therapy is safest for arthritis patients?
Arthritis therapies ranked on safety for the arthritis patient: exercise and weight loss, topical NSAIDs, PRP, hyaluronic acid, corticosteroid injections, MACI, GLP-1 agonists, oral NSAIDs, bone-marrow and adipose cell injections, exosomes and clinic 'stem cells' — with the documented harms, the interactions and what an inflammatory-arthritis patient must know.
- Best regenerative medicine treatments for osteoarthritis relief without surgery.
Non-surgical osteoarthritis treatments ranked on relief and durability: exercise, weight loss and semaglutide, topical NSAIDs, braces and aids, steroid injections, PRP, hyaluronic acid, duloxetine, stem-cell injections and exosomes — assembled into a twelve-week programme a pharmacist would prescribe.
- Best regenerative medicine options for tendon and ligament injuries.
Tendon and ligament treatments ranked by tendon and by trial: progressive loading and eccentric exercise, shockwave, PRP (works for some tendons, fails for others), corticosteroid (worse at a year), needle tenotomy, surgery, stem-cell injections and exosomes — with the evidence stated for Achilles, patellar, elbow, rotator cuff and ligament injuries.